---
title: "Bayer: acoramidis to be launched in Europe in H1 2025"
date: "2025-02-11 22:25:21"
summary: "Bayer said on Tuesday it will launch its acoramidis heart drug in Europe in the first half of this year after winning the European Commission's approval.The German drugmaker said in a statement that the drug, also known as Beyonttra, won approval for the treatment of transthyretin amyloidosis in adult patients..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Bayer said on Tuesday it will launch its acoramidis heart drug in Europe in the first half of this year after winning the European Commission's approval.

The German drugmaker said in a statement that the drug, also known as Beyonttra, won approval for the treatment of transthyretin amyloidosis in adult patients with cardiomyopathy, which results in heart failure.

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3P21CK:0-bayer-acoramidis-to-be-launched-in-europe-in-h1-2025/)
